BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:24 PM
Sep 07, 2007
 |  BC Extra  |  Financial News

Pozen up on AZN pain program, deal

POZN gained $2.78 (28%) to $12.26 on news that it and partner AstraZeneca (LSE:AZN; AZN) will begin a Phase III program this quarter for PN400, a combination of naproxen plus Nexium esomeprazole, to treat arthritis pain in patients at risk for...

Read the full 198 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >